Fast‑Track FDA Green‑Light for Lundbeck’s Narcolepsy Drug Lu AH69593
FDA grants Fast‑Track status to Lundbeck’s Lu AH69593, an oral orexin agonist for narcolepsy, speeding development and boosting patient hope and investor confidence.
2 minutes to read